Celldex Therapeutics
CLDX
#4512
Rank
โ‚ฌ2.18 B
Marketcap
27,82ย โ‚ฌ
Share price
4.30%
Change (1 day)
41.81%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -2,27ย โ‚ฌ

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -3,88ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,13ย โ‚ฌ a decrease over its 2021 EPS that were of -1,46ย โ‚ฌ.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,27ย โ‚ฌ6.41%
2022-2,13ย โ‚ฌ45.73%
2021-1,46ย โ‚ฌ-23.36%
2020-1,91ย โ‚ฌ-41.05%
2019-3,24ย โ‚ฌ-76.95%
2018-14,06ย โ‚ฌ45.03%
2017-9,70ย โ‚ฌ-42.54%
2016-16,88ย โ‚ฌ-3.82%
2015-17,55ย โ‚ฌ-0.76%
2014-17,68ย โ‚ฌ29.41%
2013-13,66ย โ‚ฌ0%
2012-13,66ย โ‚ฌ-9.73%
2011-15,13ย โ‚ฌ1312.5%
2010-1,07ย โ‚ฌ-95.79%
2009-25,43ย โ‚ฌ-49.64%
2008-50,49ย โ‚ฌ-82.64%
2007-290,91ย โ‚ฌ-44.98%
2006-528,77ย โ‚ฌ1270.83%
2005-38,57ย โ‚ฌ33.33%
2004-28,93ย โ‚ฌ-10%
2003-32,14ย โ‚ฌ-16.67%
2002-38,57ย โ‚ฌ-38.46%
2001-62,68ย โ‚ฌ-4.88%
2000-65,90ย โ‚ฌ-80.56%
1999-339,01ย โ‚ฌ-87.2%
1998-2.648ย โ‚ฌ206.39%
1997-864,09ย โ‚ฌ13.02%
1996-764,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,68ย โ‚ฌ-117.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
14,48ย โ‚ฌ-472.87%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,57ย โ‚ฌ-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-3,92ย โ‚ฌ 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,58ย โ‚ฌ-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
1,80ย โ‚ฌ-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-3,07ย โ‚ฌ-20.92%๐Ÿ‡บ๐Ÿ‡ธ USA